Breast Disease Specialty Center
乳腺专病中心 · The First Affiliated Hospital of Nanchang University, Nanchang
Established in 2023, this center integrates breast surgery, medical oncology, pathology, radiology, and ultrasound to provide multidisciplinary care for breast diseases. The team offers personalized treatment plans, including minimally invasive endoscopic surgeries such as mastectomy with implant reconstruction and lymphaticovenous anastomosis. Medical services cover chemotherapy, targeted therapy, immunotherapy, and endocrine therapy for early and late-stage breast cancer. The center manages complex cases involving comorbidities like kidney failure or heart conditions. Nursing support includes rehabilitation for lymphedema and port maintenance. Patients may access international clinical trials, such as APHINITY and DESTINY-BREAST05.
Conditions and treatments
- Endoscopic breast cancer surgery with implant reconstruction
- Supermicrosurgical lymphaticovenous anastomosis and vascularized lymph node transplantation
- Multidisciplinary treatment for breast cancer with complex comorbidities
- Chemotherapy, targeted therapy, immunotherapy, and endocrine therapy
- Preoperative diagnosis using ultrasound, mammography, MRI, and ductoscopy
- Postoperative rehabilitation for upper limb lymphedema
Key facts
- The center was established in 2023.
- The team performed over 2,000 breast tumor surgeries in 2023.
- More than 80% of the physicians hold doctoral or postdoctoral degrees.
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Breast Surgery |
|---|---|
| Doctors listed | 13 |
| Chief physicians | — |
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us